Use of heterocyclic compounds

US6090807A · kind A · utility

Assignee

• BASF SE

Inventors

• Beate Hellendahl · Mannheim, DE
• Annegret Lansky · Darmstadt, DE
• Beatrice Rendenbach-Muller · Neustadt, DE
• Alfred Bach · Heidelberg, DE
• Liliane Unger · Ludwigshafen, DE
• Hans-Jurgen Teschendorf · Dudenhofen, DE
• Carsten Wicke · Altrip, DE

Key dates

• Filing date: Jan 14, 1997
• Grant date: Jul 18, 2000
• Expiry date: Jan 14, 2017

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/26
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relate to the use of heterocyclic compounds of the following formula: EQU Het--A--B--Ar where Het, A, B and Ar have the meanings stated in the description. The compounds according to the invention have a high affinity for the dopamine D.sub.3 receptor and can therefore be used to treat disorders which respond to dopamine D.sub.3 ligands.